• English French
  • JOURNAL OF FUNCTIONAL VENTILATION AND PULMONOLOGY [Journal de la Fonction Ventilatoire et de Pneumologie]

    Last Updated: 05/07/2023

    Osa personalized treatment of obstructive sleep apnea

    Osa traitement personnalisé de l'apnée obstructive du sommeil

    S. Duong-Quy
    Lam Dong Medical College
    Penn State Medical College. Hershey Medical Center. PA, USA

    Corresponding Author:
    Pr. Sy DUONG-QUY
    Lam Dong Medical College. Dalat city. Vietnam
    Hershey Medical Center; Penn State Medical College. USA
    E-mail: sduongquy.jfvp@gmail.com

    DOI: 10.12699/jfvpulm.suppl.14.43.2023.1

    ABSTRACT

    Obstructive sleep apnea (OSA) is a common disease and often under-diagnosed and treated in all ages. This is due to differences in morphology, diversity in clinical phenotypes, and differences in diagnosis and treatment of OSA in children and adults, and even among individuals of the same age. Therefore, the approach to diagnosis and treatment of OSA according to personalized medicine is very necessary for physicians in clinical practice. Obviously, in children and in adults without serious underlying medical conditions, polysomnography at sleep labs may be inappropriate and inconvenient compared with home sleep apnea testing. In addition, apnea-hypopnea index should not be considered as a single parameter for making treatment decisions. Thus, the treatment of OSA should be personalized and based on individual tolerance to sleep quality-related parameters measured by microarousal index, harmful effect of OSA on cardiovascular system related to severe hypoxia, and patients’ comorbidities. The current treatment options for OSA include lifestyle modification, continuous positive airway pressure (CPAP) therapy, oral appliance, surgery, and other alternative treatments. CPAP therapy has been recommended as a cornerstone treatment for moderate to severe OSA in adults, however, not all patients can afford the cost, as well as the issue of CPAP intolerance. Hence, the personalized management of patients with OSA should base on pathophysiology, cluster analysis of clinical phenotypes, adequate combined therapy, and the consideration of patients’ expectations.

    RÉSUMÉ

    L'apnée obstructive du sommeil (AOS) est une maladie courante et souvent sous-diagnostiquée et traitée à tous les âges. Cela est dû aux différences de morphologie, à la diversité des phénotypes cliniques et aux différences de diagnostic et de traitement du SAOS chez les enfants et les adultes, et même chez les individus du même âge. Par conséquent, l'approche du diagnostic et du traitement de l'AOS selon la médecine personnalisée est très nécessaire pour les médecins en pratique clinique. De toute évidence, chez les enfants et les adultes sans conditions médicales sous-jacentes graves, la polysomnographie dans les laboratoires du sommeil peut être inappropriée et peu pratique par rapport aux tests d'apnée du sommeil à domicile. De plus, l'indice d'apnée-hypopnée ne doit pas être considéré comme un paramètre unique pour prendre des décisions thérapeutiques. Ainsi, le traitement de l'AOS doit être personnalisé et basé sur la tolérance individuelle aux paramètres liés à la qualité du sommeil mesurés par l'indice de micro-éveil, l'effet néfaste de l'AOS sur le système cardiovasculaire lié à une hypoxie sévère et les comorbidités des patients. Les options de traitement actuelles pour l'AOS comprennent la modification du mode de vie, la thérapie par pression positive continue (CPAP), l'appareil buccal, la chirurgie et d'autres traitements alternatifs. La thérapie CPAP a été recommandée comme traitement de base pour le SAOS modéré à sévère chez les adultes, cependant, tous les patients ne peuvent pas se permettre le coût, ainsi que le problème de l'intolérance au CPAP. Par conséquent, la prise en charge personnalisée des patients atteints d'AOS doit reposer sur la physiopathologie, l'analyse par grappes des phénotypes cliniques, une thérapie combinée adéquate et la prise en compte des attentes des patients.

    References

    1. Nguyen-Thi-Hong L., Duong-Quy. S. Obstructive Sleep Apnea Syndrome: The challenges in developing countries. J Func Vent Pulm 2016;22 (7), 1-2.
    2. Duong-Quy S., Tran-Phi D., Nguyen-Thi-Hong L., T Tang-Thi-Thao T, et al. Prevalence and Characteristic of Obstructive Sleep Apne a Syndrome in Subjects with High Blood Pressure: A Pilot Study in Vietnam. J Vasc Med Surg 2016; 4 (273), 2.
    3. Martin F., Duong-Quy S. Sleep apnea syndrome in daily practice: Welcome to the 2nd edition of sleep disorder book in French-Vietnamese languages. J Func Vent Pulm 2016;21 (7), 1-2.
    4. K Dang-Thi-Mai, NN Le-Dong, V Le-Thuong, N Tran-Van, Duong-Quy S. Exhaled nitric oxide as a surrogate marker for obstructive sleep apnea severity grading: an in-hospital population study. Nature and Science of Sleep 2021;763-773.
    5. AS BaHammam, F Han, R Gupta, S Duong-Quy, MA Al-Abri, HA Jahrami, et al. Asian accreditation of sleep medicine physicians and technologists: practice guidelines by the Asian Society of Sleep Medicine 2021; Sleep Medicine 2021;81, 246-252.
    6. Duong-Quy S, T Vu-Minh, JP Homasson, F Martin, F Soyez. Study of diagnostic value of RU Sleeping in screening of obstructive sleep apnea syndrome. J Func Vent Pulm 2013;4 (13), 30-34.
    7. H Tran-Van, A Vo-Thi-Kim, S Duong-Quy. The Study of Correlation between Diurnal Blood Pressure with Nocturnal Oxygen Desaturation and Nitrite Production in Subjects with Obstructive Sleep Apnea (OSA). Journal of Vascular Medicine & Surgery 2017;5 (3), 317.
    8. D Tran-Minh, A Phi-Thi-Quynh, P Nguyen-Dinh, S Duong-Quy. Efficacy of obstructive sleep apnea treatment by antileukotriene receptor and surgery therapy in children with adenotonsillar hypertrophy: A descriptive and cohort study Frontiers in Neurology 2022;13, 1008310.
    9. S Duong-Quy, H Nguyen-Huu, D Hoang-Chau-Bao, S Tran-Duc, et al. Personalized medicine and obstructive sleep apnea. Journal of Personalized Medicine 2022;12 (12), 2034.
    10. JWC Tan, LC Leow, S Wong, SM Khoo, T Kasai, P Kojodjojo, Duong-Quy S, et al. Asian Pacific society of cardiology consensus statements on the diagnosis and management of obstructive sleep apnoea in patients with cardiovascular disease. European Cardiology Review 2022;17.
    11. A Vo-Thi-Kim, B Nguyen-Xuan, D Dao-Van, S Duong-Quy. The Effect of Continuous Positive Airway Pressure (CPAP) in Treatment of Patients with Refractory High Blood Pressure Associated with Severe Obstructive Sleep Apnea (OSA). J Vasc Med Surg 2017;5 (327), 2.
    12. S Duong-Quy, T Hua-Huy, T Huynh-Anh, T Vu-Minh, JP Homasson, et al. Characteristics of obstructive sleep apnea in patients with arterial hypertension. J Func Vent Pulm 2013;4 (13), 35-40.
    13. S Duong-Quy, T Huynh-Anh, S Franck. Study of characteristics of obstructive sleep apnea in patients with COPD. J Func Vent Pulm 2013;4 (11), 35-40.

    ARTICLE INFO   DOI: 10.12699/jfvpulm.suppl.14.43.2023.1

    Conflict of Interest
    Non   

    Date of manuscript receiving
    10/04/2023   

    Date of publication after correction
    04/06/2023 

    Article citation

    Duong-Quy S. Osa personalized treatment of obstructive sleep apnea. J Func Vent Pulm 2023;43(14):1